Pharma Journalist -

Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in …
Read More...

NRx Pharmaceuticals a clinical stage pharmaceutical company announced that it has signed a Memorandum Of Understanding with the Government of Israel to license exclusive worldwide…
Read More...

SMi Group reports: Gain insights into developments in wearable devices in clinical trials and adapting to decentralised trials during the pandemic Wearable Injectors and Connected…
Read More...

Microbiome Connect Gut Therapeutics returns on November 17-18 for its sixth iteration; in-person, in Boston - featuring a new for 2021, dedicated manufacturing stream. 2020 was an…
Read More...

I-Mab a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the signing of two new collaborations with…
Read More...

AstraZeneca’s Biologics License Application (BLA) for tezepelumab has been accepted and granted Priority Review for the treatment of asthma from the US Food and Drug Administration…
Read More...

Verge Genomics, a biotech company that has created an industry leading all-in-human, artificial-intelligence-powered drug discovery and development platform focused on therapies for…
Read More...

INBRAIN Neuroelectronics, a company at the intersection of medtech, deeptech and digital health dedicated to developing the world’s first graphene-based intelligent neuroelectronic…
Read More...

LGM Pharma announced the launch of its new Analytical Services offering that provides analytical testing and stability services to pharmaceutical developers and manufacturers, including…
Read More...

Funding from the COVID-19 Therapeutics Accelerator to advance Exscientia’s novel class of AI-designed coronavirus SARS-CoV-2 Mpro inhibitors to development candidates OXFORD, U.K. --…
Read More...